KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Deferred Revenue (2016 - 2023)

Biolife Solutions (BLFS) has disclosed Current Deferred Revenue for 14 consecutive years, with $422000.0 as the latest value for Q1 2023.

  • Quarterly Current Deferred Revenue fell 52.85% to $422000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $422000.0 through Mar 2023, down 52.85% year-over-year, with the annual reading at $548000.0 for FY2022, 32.68% down from the prior year.
  • Current Deferred Revenue for Q1 2023 was $422000.0 at Biolife Solutions, down from $548000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $944000.0 in Q2 2021, with the low at $324000.0 in Q4 2019.
  • Average Current Deferred Revenue over 5 years is $646363.6, with a median of $662000.0 recorded in 2021.
  • The sharpest move saw Current Deferred Revenue skyrocketed 187.35% in 2020, then plummeted 54.34% in 2022.
  • Over 5 years, Current Deferred Revenue stood at $324000.0 in 2019, then surged by 187.35% to $931000.0 in 2020, then fell by 12.57% to $814000.0 in 2021, then tumbled by 32.68% to $548000.0 in 2022, then fell by 22.99% to $422000.0 in 2023.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $422000.0, $548000.0, and $429000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.